Actively Recruiting
CYP1A2 and ADORA2A Genotypes and Endurance Performance.
Led by Masaryk University · Updated on 2024-08-09
60
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this randomized, double-blind, placebo-controlled experiment will be to assess the potential effect of the selected gene polymorphism (CYP1A2, ADORA2A) on performance after caffeine ingestion.
CONDITIONS
Official Title
CYP1A2 and ADORA2A Genotypes and Endurance Performance.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy person
- Any training status
- Aged between 18 and 35 years
- No contraindications to perform the test on a bicycle trainer
- No contraindications to caffeine intake
You will not qualify if you...
- Pregnancy
- Breast feeding
- Cardiovascular disease
- Hypertension
- Liver disease in the previous two months
- Taking drugs that can affect liver function
- Illness in the 14 days before the study start
- Use of caffeine during the research period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Masaryk University
Brno, Czechia
Actively Recruiting
Research Team
D
Dominik Puda
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here